Britain on Nov. 4 became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck (MRK.N) and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
Coronavirus
Reuters: Britain approves Merck’s COVID-19 pill in world first
This handout photo obtained May 26, 2021, courtesy of Pharmaceutical company Merck, shows capsules of the experimental antiviral drug Molnupiravir.
